£135.00

It has never been this cheap. We have no record of a lower price.

£135 today · cheaper than every other day in the last 3 months

Elsevier Adenosine Receptors and Parkinson's Disease - Research Guide

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 73 days · 73 data points (no recent data)

Historical
Generating forecast…
£135.00 £128.25 £130.95 £133.65 £136.35 £139.05 £141.75 25 July 2026 12 August 2026 30 August 2026 17 September 2026 05 October 2026
View at Amazon ↗

Price data last checked 18 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 73 days • 1 price levels

Days at Price
73 days 0 18 37 55 73 £135 Days at Price

Price Analysis

Most common price: £135 (73 days, 100.0%)

Price range: £135 - £135

Price levels: 1 different prices over 73 days

Description

Adenosine Receptors and Parkinson's Disease is the first comprehensive overview of adenosine receptor antagonists and their therapeutic potential for treating Parkinson's Disease. This essential reference examines how A2A antagonist drugs work in both in vitro and in vivo systems, demonstrating their effectiveness as novel non-dopamine therapeutic agents for this debilitating neurological condition. Published by Academic Press, this book covers the discovery, development, and clinical testing of adenosine-based treatments, making it invaluable for researchers studying the basal ganglia, purine biology, and Parkinson's Disease pathophysiology. The work bridges neuropharmacology and clinical neurology, offering detailed insights into alternative drug mechanisms that complement traditional dopamine-based therapies and represent a new frontier in Parkinson's Disease management.

Key Features

Covers adenosine receptor antagonists as a novel non-dopamine treatment approach for Parkinson's Disease management.

Explains the discovery and development of A2A antagonist drugs through comprehensive research and clinical testing frameworks.

Examines both in vitro and in vivo systems to demonstrate the therapeutic potential of adenosine-based interventions.

Serves as an essential reference for researchers studying the basal ganglia, purine biology, and neurological disorders.

Published by Academic Press as a definitive overview within the Pure and Applied Mathematics academic series.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
31 October 1999
Listed Since
06 February 2007

Barcode

No barcode data available

Similar Products You Might Like

The Adenosinergic System: A Non-Dopaminergic Target in Parkinson’s Disease: 10 (Current Topics in Neurotoxicity, 10)
97% match

The Adenosinergic System: A Non-Dopaminergic Target in Parkinson’s Disease: 10 (Current Topics in Neurotoxicity, 10)

Springer

£108.75 19 Sep 2026
The Adenosine Receptors: 34 (The Receptors, 34)
96% match

The Adenosine Receptors: 34 (The Receptors, 34)

Humana

£113.73 13 Aug 2026
Adenosine Receptors in Neurology and Psychiatry - Volume 119
96% match

Adenosine Receptors in Neurology and Psychiatry - Volume 119

Elsevier

£128.00 02 Oct 2026
The Adenosinergic System: A Non-Dopaminergic Target in Parkinson’s Disease: 10 (Current Topics in Neurotoxicity)
96% match

The Adenosinergic System: A Non-Dopaminergic Target in Parkinson’s Disease: 10 (Current Topics in Neurotoxicity)

Springer

£129.99 05 Sep 2026
Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models
96% match

Clinical Studies and Therapies in Parkinson's Disease: Translations from Preclinical Models

Elsevier

£104.49 01 Oct 2026
Advances in Parkinson's Disease Management
95% match

Advances in Parkinson's Disease Management

£115.00 14 Aug 2026
Genetics, Neurology, Behavior, and Diet in Parkinson's Disease: The Neuroscience of Parkinson’s Disease, Volume 2
95% match

Genetics, Neurology, Behavior, and Diet in Parkinson's Disease: The Neuroscience of Parkinson’s Disease, Volume 2

Elsevier

£134.89 03 Sep 2026
Handbook of Atypical Parkinsonism (Cambridge Medicine (Hardcover))
95% match

Handbook of Atypical Parkinsonism (Cambridge Medicine (Hardcover))

Cambridge University Press

£51.19 07 Oct 2026
Adenosine Receptors in Health and Disease: 193 (Handbook of Experimental Pharmacology, 193)
95% match

Adenosine Receptors in Health and Disease: 193 (Handbook of Experimental Pharmacology, 193)

Springer

£120.00 12 Aug 2026
Experimental Models of Parkinson’s Disease: 2322 (Methods in Molecular Biology, 2322)
95% match

Experimental Models of Parkinson’s Disease: 2322 (Methods in Molecular Biology, 2322)

Humana

£88.21 05 Oct 2026
Adenosine Receptors in Health and Disease: 193 (Handbook of Experimental Pharmacology, 193)
95% match

Adenosine Receptors in Health and Disease: 193 (Handbook of Experimental Pharmacology, 193)

Springer

£260.49 12 Aug 2026
Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)
95% match

Cortico-Subcortical Dynamics in Parkinson’s Disease (Contemporary Neuroscience)

Humana

£80.67 21 Sep 2026
Mitochondrial Mechanisms of Degeneration and Repair in Parkinson's Disease
95% match

Mitochondrial Mechanisms of Degeneration and Repair in Parkinson's Disease

Springer

£128.77 03 Oct 2026
Parkinson Disease P'kinsonism Elder
95% match

Parkinson Disease P'kinsonism Elder

Cambridge University Press

£89.99 18 Sep 2026
Adenosine Receptors: Therapeutic Aspects for Inflammatory and Immune Diseases
95% match

Adenosine Receptors: Therapeutic Aspects for Inflammatory and Immune Diseases

CRC Press

£260.00 18 Aug 2026
Parkinson's Disease (Volume 132) (International Review of Neurobiology, Volume 132)
95% match

Parkinson's Disease (Volume 132) (International Review of Neurobiology, Volume 132)

Elsevier

£143.26 24 Sep 2026
Adenosine: A Key Link between Metabolism and Brain Activity
95% match

Adenosine: A Key Link between Metabolism and Brain Activity

Springer

£148.11 15 Aug 2026
Parkinson's Disease: Genetics and Pathogenesis (Neurological Disease and Therapy)
95% match

Parkinson's Disease: Genetics and Pathogenesis (Neurological Disease and Therapy)

CRC Press

£158.86 20 Aug 2026
Handbook of Parkinson's Disease (Neurological Disease and Therapy)
95% match

Handbook of Parkinson's Disease (Neurological Disease and Therapy)

CRC Press

£97.00 19 Aug 2026
Parkinson's Disease: Methods and Protocols - Volume 62
95% match

Parkinson's Disease: Methods and Protocols - Volume 62

Humana

£103.27 08 Oct 2026
Translational Approaches to Unravelling Non-Motor Symptoms of Parkinson’s disease (Volume 174) (International Review of Neurobiology, Volume 174)
95% match

Translational Approaches to Unravelling Non-Motor Symptoms of Parkinson’s disease (Volume 174) (International Review of Neurobiology, Volume 174)

Elsevier

£136.99 05 Sep 2026
A3 Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics
95% match

A3 Adenosine Receptors from Cell Biology to Pharmacology and Therapeutics

Springer

£144.62 24 Sep 2026
The Neuroscience of Parkinson's Disease
95% match

The Neuroscience of Parkinson's Disease

Elsevier

£230.35 15 Aug 2026
Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives: 57 (Advances in Behavioral Biology, 57)
95% match

Advances in Alzheimer's and Parkinson's Disease: Insights, Progress, and Perspectives: 57 (Advances in Behavioral Biology, 57)

Springer

£211.22 17 Sep 2026